 |
 |
Program Schedule
- Thursday, November 7, 2002
- Friday, November 8, 2002
- Saturday, November 9, 2002
- Sunday, November 10, 2002
| Sunday, November 10, 2002 | ||
| 8:00 am-9:30 am | Registration Open/Continental Breakfast | |
| 9:00 am-9:05 am | Announcements | |
| 9:05 am-11:45 am | Joint Session: New Therapies/Novel Agents | |
|
Co-Chairs: Mario Sznol,
MD |
||
| 9:05 am-9:35 am | Vector
Targeting of Cancer Cells Albert B. Deisseroth, MD, PhD Sidney Kimmel Cancer Center |
|
| 9:35 am-10:05 am | Strategies
to Improve T-Cell Migrations to Tumor Patrick Hwu, MD National Cancer Institute, NIH |
|
| 10:05 am-10:35 am | Immunocytokines:
Versatile Molecules for Biotherapy of Malignancies Ralph A. Reisfeld, PhD The Scripps Research Institute |
|
| 10:35 am-10:50 am | Refereshment Break | |
| 10:50 am-11:15 am | TRAIL
R1 and R2 mAb, A Human Agonistic Monoclonal Antibody Displays in Vitro
and in Vivo Activity on Human Tumor Cells Robin C. Humphreys, PhD Human Genome Sciences |
|
| 11:15 am-11:30 am | Vaccination
of Reconstituted Lymphopenic Hosts Facilitates Priming of Tumor-Specific
CD4+ T Cells with Therapeutic Efficacy Christian Poehlein, MD Earle A. Chiles Research Institute |
|
| 11:30 am-11:45 am | Development
of a Fever-Like Heat Treatment as an Adjuvant to Cancer Immunotherapies Michele T. Pritchard Roswell Park Cancer Institute |
|
| 11:45 am | Meeting Adjourns | |